top of page

Bringing products to market based on supporting efficacy data


By Melinna Giannini

March 8, 2022

Most healthcare product developers rely on clinical trials to establish the safety of a new product. And, while clinical trials are required to prove patient safety for surgical products and new drugs, clinical trials are not required for many non-invasive products. These have FDA safety clearance letters to assure patient safety and include products like proprietary biologics (supplements) and far-infrared heat lamps.

Manufacturers could be collecting data from coded healthcare claims with the ability to identify the cost-effectiveness of their products when compared to the cost of using conventional therapies for treating the same diagnosis.

A New Mexico company has been serving this need since 1999. To learn more, email melinna.giannini@abccodes.com.

4 views0 comments
bottom of page